There are conflicting findings whether genetic deletion of SphK2, the predominant SphK isoform in the brain (Blondeau et al., 2007) per se exacerbates ischemic damage in stroke or not (Pfeilschifter et al., 2011b; Yung et al., 2012). This evidence concerns the gene SPHK1 and stroke disorder.